Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M961Revenue $M17.2Net Margin (%)492Z-Score11.6
Enterprise Value $M862EPS $2.1Operating Margin %537F-Score7
P/E(ttm))16.6Cash Flow Per Share $-1.6Pre-tax Margin (%)502Higher ROA y-yY
Price/Book11.410-y EBITDA Growth Rate %0Quick Ratio5.8Cash flow > EarningsY
Price/Sales50.85-y EBITDA Growth Rate %0Current Ratio5.8Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)49.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)69.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M41.9ROI % (ttm)-221.3Gross Margin Increase y-yN

Gurus Latest Trades with ANAC

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ANACJean-Marie Eveillard 2013-03-31 Sold Out -0.0017%$3.15 - $6.52
($4.32)
$ 22.66424%Sold Out0
ANACJean-Marie Eveillard 2012-12-31 Buy $4.6 - $6.81
($5.55)
$ 22.66308%New holding, 92390 sh.92,390
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ANAC is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ANAC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Maples Kirk RSVP, Program Management 2014-08-13Sell3,959$19.9614.63 view
Plattner Jacob jSenior VP, Research 2014-08-13Sell6,875$2014.4 view
Maples Kirk RSVP, Program Management 2014-06-04Sell1,620$14.755.65 view
Maples Kirk RSVP, Program Management 2014-05-20Sell1,500$14.1561.7 view
Maples Kirk RSVP, Program Management 2014-04-21Sell1,500$15.646.67 view
Parker Geoffrey M.Senior Vice President and CFO 2014-03-24Buy5,000$20.1113.77 view
Shapiro LucyDirector 2014-03-21Sell80,000$21.148.23 view
Maples Kirk RSVP, Program Management 2014-03-20Sell3,000$22.392.19 view
Parker Geoffrey M.Senior Vice President and CFO 2014-03-18Buy2,410$22.61.24 view
PERRY DAVID PPresident and CEO 2014-03-05Sell65,000$20.2213.16 view

Press Releases about ANAC :

    Quarterly/Annual Reports about ANAC:

    News about ANAC:

    Articles On GuruFocus.com
    Paulson Bets Again On Mallinckrodt Aug 07 2014 
    3 Great Dividend Stocks at All-Time Highs Aug 19 2013 
    Weekly CFO Buys Highlight Aug 19 2013 
    Senior Vice President and CFO of Anacor Pharmaceuticals Inc. Geoffrey Parker Bought 43,046 Shares Jun 20 2013 
    This Week's Top Insider Buys Jun 19 2013 
    comment on ANAC Mar 15 2013 
    Weekly CFO Buys Highlight: SSP, BMTI, POL, ANAC, CYTX Mar 26 2012 
    Weekly CFO Buys Highlight: GSVC, SHO, YAVY, CMCSA, ANAC May 16 2011 

    More From Other Websites
    ANACOR PHARMACEUTICALS, INC. Financials Aug 19 2014
    Rigel's R348 Fails in Phase II Study, Shares Down 13.6% Aug 14 2014
    Anacor (ANAC) Shares March Higher, Can It Continue? Aug 13 2014
    AVEO Pharmaceuticals Posts Narrower-than-Expected Q2 Loss Aug 13 2014
    Anacor's Q2 Loss Narrower than Expected, Kerydin in Focus Aug 12 2014
    Salix Pharmaceuticals Beats on Q2 Earnings, Cuts Guidance Aug 12 2014
    ARIAD Falls on Wider-than-Expected Loss, Revenues Miss Aug 11 2014
    ANACOR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Aug 11 2014
    ANACOR PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 07 2014
    Anacor Pharmaceuticals Reports Second Quarter 2014 Financial Results Aug 07 2014
    Anacor Pharmaceuticals to Present at Upcoming Investor Conferences Aug 07 2014
    Q2 2014 Anacor Pharmaceuticals Inc Earnings Release - After Market Close Aug 07 2014
    Should You Buy Anacor Pharmaceuticals (ANAC) Ahead of Earnings? Aug 06 2014
    Anacor Pharmaceuticals Announces Second Quarter 2014 Financial Results Conference Call and Webcast Aug 01 2014
    Anacor's Kerydin to Be Commercialized by Sandoz in the U.S. Jul 22 2014
    Anacor Pharmaceuticals, Inc. (ANAC) in Focus: Stock Surges 6.76% Jul 22 2014
    ANACOR PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jul 21 2014
    Anacor Pharmaceuticals and Sandoz Enter Into an Agreement for the Commercialization of KERYDIN in... Jul 21 2014
    Anacor's Kerydin Gets FDA Nod for Onychomycosis Jul 09 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK